187 related articles for article (PubMed ID: 9163877)
21. Proliferative activity in oral salivary gland tumors: the role of PCNA and AgNOR assessed by a double staining technique.
Rivero ER; Caliari MV; Tarquínio SB; Loyola AM; de Aguiar MC
J Oral Sci; 2004 Jun; 46(2):87-92. PubMed ID: 15287541
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
23. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
24. An improved system for quantifying AgNOR and PCNA in canine tumors.
Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
26. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
27. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of canine mast cell tumors: a comparison of three methods.
Simoes JP; Schoning P; Butine M
Vet Pathol; 1994 Nov; 31(6):637-47. PubMed ID: 7863578
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
30. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa.
Irazusta SP; Vassallo J; Magna LA; Metze K; Trevisan M
Pathol Res Pract; 1998; 194(1):33-9. PubMed ID: 9542745
[TBL] [Abstract][Full Text] [Related]
31. Cell kinetics analysis in stage I endometrial carcinoma as determined by image cytometry and immunohistochemistry. Correlation with clinicopathologic characteristics.
Miliaras D; Papaemmanuil S
Anal Quant Cytol Histol; 2004 Feb; 26(1):7-14. PubMed ID: 15032075
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of standardized AgNOR analysis and Ki-67 immunostaining in gastrointestinal stromal tumors.
Rodolico V; Martorana A; Gulotta G; Diana G; Leonardi V; Cocorullo G; Ajello F
Anal Quant Cytol Histol; 2003 Aug; 25(4):199-209. PubMed ID: 12961826
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
[TBL] [Abstract][Full Text] [Related]
37. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
38. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
[TBL] [Abstract][Full Text] [Related]
39. Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors.
Bundgaard-Andersen K; Flagstad A; Jensen AL; Hellmén E; Trerè D
J Vet Intern Med; 2008; 22(5):1174-80. PubMed ID: 18624984
[TBL] [Abstract][Full Text] [Related]
40. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]